BriefMeBro is now free — every edition, no signup. briefmebro.com
BRIEFMEBRO· The 30-second world & markets brief — including the stories they buried.
65SCIENCE

Genetically modified pig kidney functions in a human for a record 9 months

⚡ Markets: Long-term positive for biotech companies involved in gene-editing and xenotransplantation. Could revolutionize the multi-billion dollar organ transplant and dialysis markets.Biotech ETFsGene-editing stocks

In a major xenotransplantation milestone, a pig kidney that was genetically edited to be compatible with humans kept a 66-year-old man alive and off dialysis for nine months. The procedure represents the longest time such an organ has functioned in a living person and successfully acted as a 'bridge' until a human kidney became available for transplant.

West MSM 1Google West 1Sci/Tech press 12 countries
3 sources across the spectrum
← Full brief